11− FURUTA, T. et al. Polymorphism of interleukyn-1beta affects the eradication
rates of Helicobacter pylori in triple therapy. Clin Gastroenterol Hepatol; v.2,
n.1: p.22-30, 2004.
12− GRAHAM, D.Y. et al. Twice daily (mid-day and evening) quadruple therapy
for H. pylori infection in the United States. Dig Liver Dis; v.36, n.6: p.384-7,
2004.
13− GISBERT, J.P.; PAJARES, J.M. Helicobacter pylori ‘rescue’ regimen when
proton pump inhibitor-based triple therapies fail. Aliment Pharmacol Ther;
v.16, n.6: p.1047-57, 2002.
14− MÉGRAUD, F. H. pylori antibiotic resistance: prevalence, importance, and
advances in testing. Gut; v.53, n.9: p.1374-84, 2004.
15− GISBERT, J.P. et al. ‘Rescue’ Therapy with rifabutin after multiple Helicobacter
pylori treatment failures. Helicobacter; v.8, n.2: p.90-94, 2003.
16− ZULLO, A. et al. A third-line levofloxacin-based rescue therapy for Helicobacter
pylori eradication. Dig Liver Dis; v.35, n.4: p.232-6, 2003.
17− MATSUZAKI, K. et al. In vitro activities of levofloxacin and other antibiotics
against fresh clinical isolates. Jpn J Antibiot; v.52, n.9: p.571-84, 1999.
18− CAMMAROTA, G. et al. Efficacy of two one-week rabeprazole/levofloxacin-
based triple therapies for Helicobacter pylori infection. Aliment Pharmacol
Ther; v.14, n.10: p.1339-1343, 2000.
19− GISBERT, J.P. et al. First-line triple therapy with levofloxacin for Helicobacter
pylori eradication. Aliment Pharmacol Ther; v.26, n.3: p.495-500, 2007.
20− ZATERKA, S. et al. A multicenter study to compare the efficacy and safety of
3-7-day rabeprazole (RAB)-based triple therapy regimens for Helicobacter pylori
eradication. Abstract DDW, pg. A-482, 2003.
21− COELHO, L.G. et al. Once-daily, low-cost, highly effective Helicobacter pylori
treatment to family members of gastric cancer patients. Aliment Pharmacol
Ther; v.17, n.1: p.131-6, 2003.
22− COELHO, L.G.; LÉON-BARÚA, R.; QUIGLEY, E.M.M. Latin American
Consensus Conference on Helicobacter pylori infection. Latin-American
National Gastroenterological Societies affiliated with the Inter-American
Association of Gastroenterology (AIGE). Am J Gastroenterol; v.95, n.10:
p.2688-91, 2000.
23− GISBERT, J.P. et al. Levofloxacin- vs. ranitidine bismuth citrate-containing
therapy after H. pylori treatment failure. Helicobacter; v.12, n.1: p.68-73, 2007.
24− COELHO, L.G. et al. New once-daily, highly effective rescue triple therapy after
multiple Helicobacter pylori treatment failures: a pilot study. Aliment
Pharmacol Ther; v.21, n.6: p.783-7, 2005.